Preliminary observations of oral nicotine therapy for inflammatory bowel disease: An open-label phase I-II study of tolerance

Inflammatory Bowel Diseases

Volumn 11, Issue 12, 2005, Pages 1092-1096

  Ingram, John Robert ^a   Rhodes, John ^a   Evans, Brian K ^b   Thomas, Gareth A O ^a,c  

^a CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^b Quadrant Centre   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Inflammatory bowel disease; Oral nicotine

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; NICOLON; NICOTINE; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG SAFETY; DRUG TOLERABILITY; ENTERITIS; FEMALE; FOLLOW UP; GLOSSITIS; HEADACHE; HEART PALPITATION; HUMAN; LOW BACK PAIN; MALE; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SLEEP DISORDER; SWEATING; SYMPTOM; TASTE DISORDER; TINNITUS; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TREMOR; URINE RETENTION; VIVID DREAM;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; TREATMENT OUTCOME;

EID: 27944493536     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.3780111209     Document Type: Article

References (18)

1. Harries AD, Baird A, Rhodes J. Nonsmoking: a feature of ulcerative colitis. BMJ. 1982;284:706.
2. Jick H, Walker AM. Cigarette smoking and ulcerative colitis. N Engl J Med. 1983;308:261-263.
3. Boyko EJ, Koepsell TD, Perera DR, et al. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med. 1987;316: 707-710.
4. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989;34:1841-1854.
5. Rudra T, Motley R, Rhodes J. Does smoking improve colitis? Scand J Gastroenterol Suppl. 1989;170:61-63.
6. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med. 1994;330:811-815.
7. Sandborn WJ, Tremaine W, Offord KP, et al. Transdermal nicotine for mildly to moderately active ulcerative colitis, a randomised, double-blind, placebo-controlled trial. Ann Intern Med. 1997;126:364-371.
8. McGrath J, McDonald J, Macdonald J. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2004;4:CD004722.
9. Ingram JR, Routledge P, Rhodes J, et al. Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine. Aliment Pharmacol Ther. 2004;20:859-865.
10. Green JT, Evans BK, Rhodes J, et al. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. Br J Clin Pharmacol. 1999;48:485-493.
11. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24(Suppl. 170):2-6.
12. Henningfield JE, Heishman SJ. Behavioural toxicology of nicotine. In: Benowitz NL, ed. Nicotine Safety and Toxicity. New York: Oxford University Press, 1998:134-135.
13. Compton RF, Sandborn WJ, Lawson GM, et al. A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration. Aliment Pharmacol Ther. 1997;11:865-874.
14. Green JT, Thomas GAO, Rhodes J, et al. Nicotine enemas for active ulcerative colitis - a pilot study. Aliment Pharmacol Ther. 1997;11:859-863.
15. Sandborn WJ, Tremaine WJ, Leighton JA, et al. Nicotine tartrate enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study. Aliment Pharmacol Ther. 1997;11:663-671.
16. Jameson JS, Rogers J, Raimundo AH, et al. The effect of nicotine and its metabolites on the distal colon. Gastroenterology. 1993;104:A527.
17. Ryan WR, Allan RN, Yamamoto T, et al. Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence. Am J Surg. 2004;187:219-225.
18. Hatoum OA, Binion DG, Otterson MF, et al. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilatation. Gastroenterology. 2003;125:58-69.